2026 Annual Meeting | S8 - Multiple Sclerosis: Imaging, Biomarkers, and Environmental Exposures

Date Sunday 04/19/26

Time 03:30 PM - 05:30 PM CDT Add To Calendar

Location McCormick Place West | W178a

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Scientific Platform Session

Moderator(s) Susan Gauthier, DO, Dalia Rotstein, MD

Topic(s) Multiple Sclerosis

CME Available 2.00 CME credits

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:54 PM CDT	Speaker	2026 John Dystel Prize for Multiple Sclerosis Research: This prize recognizes outstanding contributions to research that have led to breakthroughs in the understanding, prevention, treatment, or cure of MS Ludwig Kappos, MD, FAAN
03:54 PM - 04:06 PM CDT	Abstract	003 - Preservation of Ambulation and Hand Function at Healthy-control Levels With First-line Treatment With Ocrelizumab: Six-year Findings From the ENSEMBLE Trial Robert A. Bermel, MD, FAAN
04:06 PM - 04:18 PM CDT	Abstract	004 - Assessing Optic Nerve Involvement in Multiple Sclerosis With and Without History of Optic Neuritis Using OCT and MRI Alessandro Gualco, MD
04:18 PM - 04:30 PM CDT	Abstract	005 - Impact of Air Pollution on Disease Exacerbations in Central Demyelinating Disorders Chutithep Teekaput, MD, PhD
04:30 PM - 04:42 PM CDT	Abstract	006 - Aerobic Training and Potential Neurogenesis in Progressive Multiple Sclerosis: Focus on the Hippocampus and the Subventricular Zone Tetsu Morozumi, PT
04:42 PM - 04:54 PM CDT	Abstract	007 - Regional Cortical Demyelination Predicts Word-Finding Difficulty in Early Multiple Sclerosis Madeline Cheshire
04:54 PM - 05:06 PM CDT	Abstract	008 - A CSF Disease-associated Macrophage Signature Defines Progressive Multiple Sclerosis Raphael Bernard-Valnet, MD, PhD
05:06 PM - 05:18 PM CDT	Abstract	009 - Eye-tracking as a Digital Biomarker of Processing Speed and Mobility in Multiple Sclerosis Diogo Haddad Santos, MD
05:18 PM - 05:30 PM CDT	Abstract	010 - Real-world Utilization of a Novel Multi-analyte Blood-based Biomarker Panel, the Octave® Multiple Sclerosis Disease Activity (MSDA) Test in Clinical Practice Across the United States Darin T. Okuda, MD, FAAN

Faculty Disclosures
James F. Sumowski	Mr. Sumowski has nothing to disclose.
Renato Anghinah, MD, FAAN	Dr. Anghinah has nothing to disclose.
Robert A. Bermel, MD, FAAN	Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Ludo J. Vanopdenbosch, MD, FAAN	Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for celgene. Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F Hoffmann La Roche. Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme.
Anthony Feinstein, MD	Anthony Feinstein, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis, Biogen, Roche and Sanofi-Genzyme. The institution of Anthony Feinstein, MD has received research support from Multiple Sclerosis Society of Canada. Anthony Feinstein, MD has received publishing royalties from a publication relating to health care.
Batuhan Ayci, MD	Mr. Ayci has nothing to disclose.
Thomas A. Berger, MD	Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
Carolina B. Moura, MD	Dr. Moura has nothing to disclose.
Catharina Gross, PhD	Dr. Gross has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for DIU Dresden International GmbH. The institution of Dr. Gross has received research support from Biogen, Roche, and Sanofi. Dr. Gross has received intellectual property interests from a discovery or technology relating to health care.
Cecilia Meza	Cecilia Meza has nothing to disclose.
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Anna-Lena Boersch, Msc	Mrs. Boersch has nothing to disclose.
Chutithep Teekaput, MD, PhD	Dr. Teekaput has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Pfizer. Dr. Teekaput has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for BL Hua. The institution of Dr. Teekaput has received research support from Chiang Mai University.
Matilde Inglese, MD, PhD	Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK-SERONO. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Inglese has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MS Journal.
Helena Feng	Miss Feng has nothing to disclose.
Frederike Straeten	Frederike Straeten has nothing to disclose.
Vincenzo Daniele Boccia	Vincenzo Daniele Boccia has nothing to disclose.
Alessandro Meani	Alessandro Meani has nothing to disclose.
Rob Motl	No disclosure on file
Brian Sandroff	The institution of Brian Sandroff has received research support from NIH, NIDILRR, National MS Society.
Qingying Feng	Miss Feng has nothing to disclose.
Caio Goes	No disclosure on file
Alex Kinderman	No disclosure on file
Suzanne Moore	Suzanne Moore has received personal compensation for serving as an employee of Hoffmann-la-Roche. Suzanne Moore has stock in Hoffmann-la-Roche.
Gerd Meyer Zu Horste, MD	Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant, Argenx, Johnson&Johnson. Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen, Argenx, Sanofi. The institution of Dr. Meyer Zu Horste has received research support from Roche. Dr. Meyer Zu Horste has received intellectual property interests from a discovery or technology relating to health care.
Trygve Holmoy, MD	Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Norwegian MS Society. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Giacomo Boffa	Mr. Boffa has nothing to disclose.
Emma Dereskewicz	Ms. Dereskewicz has nothing to disclose.
Louisa Müller-Miny	The institution of Dr. Müller-Miny has received research support from Innovative Medical Research Münster .
Jennifer Freeman	Jennifer Freeman has nothing to disclose.
Jonadab Dos Santos Silva, MD, PhD	Dr. Dos Santos Silva has nothing to disclose.
Elisa Sheng	Dr. Sheng has received personal compensation for serving as an employee of Octave Bioscience.
Maria P. Amato, PhD	Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOU Careggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi genzyme. The institution of Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene BMS. The institution of Dr. Amato has received research support from Merck. The institution of Dr. Amato has received research support from Biogen. The institution of Dr. Amato has received research support from Roche.
Tetsu Morozumi, PT	Mr. Morozumi has nothing to disclose.
Peter Feys	Peter Feys has nothing to disclose.
David Brazel, PhD	Dr. Brazel has received personal compensation for serving as an employee of Octave Bio. Dr. Brazel has or had stock in Octave Bio. The institution of Dr. Brazel has received research support from MJFF. The institution of an immediate family member of Dr. Brazel has received research support from DOE/NASA/DOD.
Michael Heming, MD	The institution of Dr. Heming has received research support from Interdisciplinary Center for Clinical Research. Dr. Heming has received intellectual property interests from a discovery or technology relating to health care. Dr. Heming has received intellectual property interests from a discovery or technology relating to health care.
Ulrik Dalgas	Ulrik Dalgas has received personal compensation for serving as an employee of Roche. Ulrik Dalgas has received personal compensation for serving as an employee of Bristol Meyers Squibb.
Diogo Haddad Santos, MD	Dr. Haddad Santos has nothing to disclose.
Dagoberto Callegaro, PhD	No disclosure on file
Paola Valsasina	Paola Valsasina has nothing to disclose.
Erin S. Beck, MD	Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Glaxo Smith Kline. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharmaceutical Corporation. An immediate family member of Dr. Beck has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Swedish Orphan Biovitrum AB. The institution of Dr. Beck has received research support from National Multiple Sclerosis Society. The institution of Dr. Beck has received research support from National Institutes of Health. The institution of Dr. Beck has received research support from United States Department of Defense. The institution of Dr. Beck has received research support from Consortium of Multiple Sclerosis Centers. Dr. Beck has received intellectual property interests from a discovery or technology relating to health care.
Alessandro Gualco, MD	Dr. Gualco has nothing to disclose.
Sydni Martinez, PharmD	Miss Martinez has nothing to disclose.
Madeline Cheshire	Ms. Cheshire has nothing to disclose.
Amber Salter, PhD	Dr. Salter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gryphon Bio. Dr. Salter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abata Therapeutics. Dr. Salter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sora Neuroscience. Dr. Salter has stock in Owl Therapeutics. The institution of Dr. Salter has received research support from National Multiple Sclerosis Society. The institution of Dr. Salter has received research support from Department of Defense Congressionally Directed Medical Research Program. The institution of Dr. Salter has received research support from Consortium of Multiple Sclerosis Centers.
Amanda C. Rodrigues, MS	Miss Rodrigues has nothing to disclose.
Ralph H. Benedict, PhD	Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic Therapeutics. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Sara Garbarino	Dr. Garbarino has nothing to disclose.
Gary R. Cutter, PhD	Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Rafael P. Castello dias Carneiro, dr	No disclosure on file
Julia Galasso	Ms. Galasso has nothing to disclose.
Ferhan Qureshi	Mr. Qureshi has received personal compensation for serving as an employee of Octave Bioscience.
Licinio M. Craveiro, MD, PhD	Dr. Craveiro has received personal compensation for serving as an employee of Hoffmann La-Roche. Dr. Craveiro has received stock or an ownership interest from Hoffmann La-Roche.
Xuesong Wang	Dr. Wang has nothing to disclose.
Ludwig Kappos, MD, FAAN	Dr. Kappos has nothing to disclose.
Rachel A. Farrell, MD	The institution of Dr. Farrell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharma / Jazz. The institution of Dr. Farrell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz.
Chiara Razzetta, PhD	Dr. Razzetta has nothing to disclose.
Darin T. Okuda, MD, FAAN	Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortechs AI. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas BioPharma. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from Alexion. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.
Jonathan Verrier, PhD	Dr. Verrier has received personal compensation for serving as an employee of Octave Bioscience . Dr. Verrier has received personal compensation for serving as an employee of EMD Serono.
Giampaolo Brichetto, MD, PhD	Giampaolo Brichetto, MD, PhD has received personal compensation for serving as an employee of Italian MS Society.
Jeremy S. Chataway, MD	Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janseen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NerveGen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Maria Cellerino, MD	Maria Cellerino has nothing to disclose.
Paolo Preziosa	Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Nancy Chiaravalloti	The institution of Nancy Chiaravalloti has received research support from NIH. The institution of Nancy Chiaravalloti has received research support from NIDILRR.
John DeLuca, PhD, ABPP	Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. DeLuca has received research support from Biogen.
Joep Killestein	Joep Killestein has nothing to disclose.
Susan Gauthier, DO	Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Gauthier has received research support from Genentech.
Francesco La Rosa, PhD	Dr. La Rosa has nothing to disclose.
Andreas Schulte-Mecklenbeck	Andreas Schulte-Mecklenbeck has nothing to disclose.
Raphael Bernard-Valnet, MD, PhD	The institution of Dr. Bernard-Valnet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Juvisé. The institution of Dr. Bernard-Valnet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Bernard-Valnet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Dr. Bernard-Valnet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Bernard-Valnet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Bernard-Valnet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Dr. Bernard-Valnet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. The institution of Dr. Bernard-Valnet has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Bernard-Valnet has received research support from Novartis Foundation. The institution of Dr. Bernard-Valnet has received research support from Helmut-Horten Foundation. The institution of Dr. Bernard-Valnet has received research support from Baasch-Medicus Foundation.
Dalia Rotstein, MD	Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen/Horizon . Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Aventis. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion . Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Rotstein has received research support from MS Canada. The institution of Dr. Rotstein has received research support from National MS Society. Dr. Rotstein has received research support from Li Ka Shing Knowledge Institute. The institution of Dr. Rotstein has received research support from University of Toronto Division of Neurology. The institution of Dr. Rotstein has received research support from Canada's Drug Agency. The institution of Dr. Rotstein has received research support from Amgen. The institution of Dr. Rotstein has received research support from Alexion. The institution of Dr. Rotstein has received research support from Guthy Jackson Foundation .
Gargi Datta, PhD	Dr. Datta has received personal compensation for serving as an employee of Octave Bioscience. Dr. Datta has received personal compensation for serving as an employee of Kytopen. Dr. Datta has received personal compensation for serving as an employee of Artisan Bio. Dr. Datta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Octave Bioscience. Dr. Datta has a non-compensated relationship as a Scientific Advisory Board Member with Sophie's Neighborhood that is relevant to AAN interests or activities.
Terrie Livingston, PharmD	Ms. Livingston has received personal compensation for serving as an employee of Octave Bioscience. Ms. Livingston has received personal compensation for serving as an employee of EMD Serono. Ms. Livingston has or had stock in Biogen.Ms. Livingston has or had stock in Octave Bioscience.Ms. Livingston has a non-compensated relationship as a Board of Directors with MSAA that is relevant to AAN interests or activities.